Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Gross Margin (2019 - 2021)

Historic Gross Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 100.0%.

  • Benitec Biopharma's Gross Margin changed N/A to 100.0% in Q2 2023 from the same period last year, while for Mar 2024 it was 1471.43%, marking a year-over-year decrease of 15581900.0%. This contributed to the annual value of 100.0% for FY2023, which is 123300.0% up from last year.
  • Per Benitec Biopharma's latest filing, its Gross Margin stood at 100.0% for Q2 2023.
  • In the past 5 years, Benitec Biopharma's Gross Margin registered a high of 100.0% during Q4 2021, and its lowest value of 1800.0% during Q4 2020.
  • In the last 5 years, Benitec Biopharma's Gross Margin had a median value of 21.21% in 2019 and averaged 182.68%.
  • As far as peak fluctuations go, Benitec Biopharma's Gross Margin crashed by -15026000bps in 2020, and later skyrocketed by 19000000bps in 2021.
  • Benitec Biopharma's Gross Margin (Quarter) stood at 297.4% in 2019, then plummeted by -505bps to 1800.0% in 2020, then skyrocketed by 106bps to 100.0% in 2021, then changed by 0bps to 100.0% in 2022, then changed by 0bps to 100.0% in 2023.
  • Its Gross Margin stands at 100.0% for Q2 2023, versus 100.0% for Q1 2023 and 100.0% for Q4 2022.